Publications by authors named "Prema Abraham"

Claim this Profile
E
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.
Charles C Wykoff, David M Brown, Kimberly Reed, Alyson J Berliner, Adam T Gerstenblith, Prema Abraham

JAMA Ophthalmol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes: A Randomized Clinical Trial.
Clement K Chan, Maziar Lalezary, Prema Abraham, Michael Elman, Wesley Thomas Beaulieu

Ophthalmol Retina· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-hoc analysis of single nucleotide polymorphism profile for eyes with vascularized pigment epithelial detachment due to ARMD.
Daniel Lee, Clement K Chan, Prema Abraham, David Sarraf

Eur J Ophthalmol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single nucleotide polymorphism profiles associated with three common phenotypes of advanced age-related macular degeneration.
Caleb C Ng, Clement K Chan, Prema Abraham, Andre D Hafner

Acta Ophthalmol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meticulous multimodal analysis of aflibercept therapy for submacular vascularized pigment epithelial detachment associated with neovascular AMD in a prospective case series, the EVEN study.
Clement K Chan, David Sarraf, Prema Abraham, Maziar Lalezary, Steven G Lin

Am J Ophthalmol Case Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
David S Liao, Federico V Grossi, Delphine El Mehdi, Monica R Gerber, David M Brown, Prema Abraham

Ophthalmology· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes of conventional or high-dose ranibizumab for vascularized pigment epithelial detachment based on lesion subtypes.
Clement K Chan, David Sarraf, Prema Abraham

Eur J Ophthalmol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TYPE 1 VERSUS TYPE 3 NEOVASCULARIZATION IN PIGMENT EPITHELIAL DETACHMENTS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: A Prospective Study.
Xuejing Chen, Mayss Al-Sheikh, Clement K Chan, Amir H Hariri, Prema Abraham

Retina· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy.
David Sarraf, Clement Chan, Ehsan Rahimy, Prema Abraham

Retina· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration.
David M Brown, Jeffrey S Heier, Thomas Ciulla, Matthew Benz, Prema Abraham

Ophthalmology· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial.
Jeffrey S Heier, David Brown, Thomas Ciulla, Prema Abraham, Joy M Bankert

Ophthalmology· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.
Quan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, Roomasa Channa, Elham Hatef, Prema Abraham

Ophthalmology· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2.
Prema Abraham, Huibin Yue, Laura Wilson

Am J Ophthalmol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
Clement K Chan, Prema Abraham, Carsten H Meyer, Gregg T Kokame, Peter K Kaiser

Retina· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.
Quan Dong Nguyen, Syed Mahmood Shah, Jeffery S Heier, Diana V Do, Jennifer Lim, Prema Abraham

Ophthalmology· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy.
David Dyer, David Callanan, Thomas Bochow, Prema Abraham, H Michael Lambert

Retina· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.
Carl D Regillo, David M Brown, Prema Abraham, Huibin Yue, Tsontcho Ianchulev

Am J Ophthalmol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal bevacizumab (avastin) in central retinal vein occlusion.
Jason Hsu, Richard S Kaiser, Arunan Sivalingam, Prema Abraham, Mitchell S Fineman

Retina· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Clement K Chan, Carsten H Meyer, Jeffrey G Gross, Prema Abraham, Asha S D Nuthi

Retina· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis